NPPA Fixes Cost of 84 Drug Formulations

The retail prices of 84 essential drug formulations, used in the treatment of several diseases, has been fixed by the National Pharmaceutical Pricing Authority (NPPA), the regulatory body under the Union Ministry of Chemicals and Fertilizers.



Pharmaceutical companies are required to strictly adhere to the fixed prices, failing to which they would be liable to pay the overcharged amount along with interest, the NPPA said in a notification.

The drug formulations whose prices have been fixed include those used in the treatment of type 2 diabetes, high blood pressure and gastrointestinal disorders, as well as the medicines that are taken to reduce triglycerides levels in blood to prevent heart attack and stroke.

The price of Atorvastatin and Fenofibrate tablet, sold by Cipla and Pure & Care Healthcare, has been fixed at Rs 13.87 per tablet. The medicine is used by the patients suffering from heart diseases and diabetes.

The regulator has also fixed the price of a single tablet of Voglibose and (SR) Metformin Hydrochloride at Rs 10.47, excluding GST.

Similarly, the price of Paracetamol and Caffeine has been fixed at Rs 2.88 per tablet. Besides, the price of one Rosuvastatin Aspirin and Clopidogrel capsule has been fixed at Rs 13.91. NPPA, in its order, has asked the drug makers to submit a price list through the Integrated Pharmaceutical Database Management System (IPDMS), CNBC-TV18 reported. A copy of the same should also be provided to the state drug controllers, it reportedly added.

"As per para 24(4) of DPCO 2013, every retailer and dealer shall display price list and the supplementary price list, if any, as furnished by the manufacturer, on a conspicuous part of the premises where he carries on business in a manner so as to be easily accessible to any person wishing to consult the same," the news channel quoted the order as stating.

In a separate notification, NPPA said it has extended the revised ceiling price of liquid medical oxygen and oxygen inhalation (medicinal gas) till September 30 this year.

The NPPA, notably, is mandated to fix or revise the prices of controlled bulk drugs and formulations and enforce prices and availability of the medicines in the country. It also monitors the prices of decontrolled drugs in order to keep them at reasonable levels.

(With PTI inputs)
Dr Rohit Bhaskar, Physio
Dr Rohit Bhaskar, Physio Dr. Rohit Bhaskar, Physio is Founder of Bhaskar Health and Physiotherapy and is also a consulting physiotherapist. He completed his Graduation in Physiotherapy from Uttar Pradesh University of Medical Sciences. His clinical interests are in Chest Physiotherapy, stroke rehab, parkinson’s and head injury rehab. Bhaskar Health is dedicated to readers, doctors, physiotherapists, nurses, paramedics, pharmacists and other healthcare professionals. Bhaskar Health audience is the reason I feel so passionate about this project, so thanks for reading and sharing Bhaskar Health.

Post a Comment

Listen to this article